Shipment term

Aurora Cannabis delivers approximately $10 million worth of medical cannabis to Israel


Considered the largest shipment of medical cannabis to Israel nowadays
Aurora continues to advance its strategic leadership in the global cannabinoid industry

EDMONTON, Alta., January 4, 2022 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids around the world, today announced the delivery of ‘a shipment of cannabis worth approximately 10 million Canadian dollars – the company’s largest expedition to Israel, and what is believed to be the largest medical cannabis export to the Israeli market. Delivered in December, the delivery will be counted as revenue during Aurora’s FY22 Q2 period.

The sale builds on the Company’s growing presence in Israel, a key market as Aurora continues to strengthen its international medical business. As the world’s largest Canadian licensed producer (LP) of medical cannabis by revenue, Aurora has strategically focused on international expansion to strengthen its diversified business portfolio. The Company also recently entered into a joint venture in The Netherlands participate in the Cannabis Controlled Supply Chain Experiment, a pilot program for adults.

“These are exciting times for the global cannabis industry as we see growing acceptance and thoughtful regulation of medical and adult cannabis across Europe and in key markets like Israel,” says Michael Martin, CEO of Aurora. “With strong local relationships, as well as the support of our patients and consumers, we look forward to continuing to grow our international business to complement our total cannabis portfolio.”

About Aurora:

Aurora is a global leader in the cannabis industry, serving both medical and consumer markets. Based at Edmonton, AB, Aurora is a global cannabis pioneer dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Drift of the Northern Lights, Saint-Raphael ’71, Special of the day, MedReleaf, CanniMed, Pedanios, whistler, reliva and KG7 CBD. Driven by science and innovation, and focused on high-quality cannabis products, Aurora’s brands continue to stand out as industry leaders in the medical, performance, wellness and leisure for adults, wherever they are launched. Learn more about and follow us on Twitter and LinkedIn.
Aurora’s common shares trade on the TSX and NASDAQ under the symbol “ACB” and are included in the S&P/TSX Composite Index.

Forward-looking information

This press release contains statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are often characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements made in this press release include, but are not limited to, statements regarding the Company’s continued supply of medical cannabis to Israel and the continued expansion of the Company’s international medical activities.

These forward-looking statements are only predictions. The forward-looking information or statements contained in this press release have been prepared based on assumptions that management believes to be reasonable. Important factors or assumptions involved in making forward-looking statements include, but are not limited to, publicly available information from government sources as well as market research and industry analysis and assumptions based on data and knowledge of this industry that the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes are relevant and reasonable under the circumstances and which could cause events, results, level of activity, performance Actual prospects, opportunities or achievements differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue to invest in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of government and non-government third-party consumer sales channels, management estimates of consumer demand in Canada and in jurisdictions to which the Company exports, expectations of future results and expenses, the risk of successful integration of acquired businesses and operations, management’s estimate that general and administrative expenses will only increase in proportion to revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the performance of cannabis cultivation operations, demand for products, price changes of required products, competition and the possibility of changes in laws, industry rules and regulations, epidemics, pandemics or other public health crises, including outbreak current situation of COVID-19, and other risks, uncertainties and factors set forth under the heading “Risk Factors” in the Company’s Annual Information Form dated September 27, 2021 (the “Annual Information Form”) and filed with the Canadian securities authorities available on the Company’s issuer profile on SEDAR at and filed with and available on the SEC’s website at The Company warns that the list of risks, uncertainties and other factors described in the annual information form is not exhaustive and that other factors could also have an adverse effect on its results. Readers are urged to carefully consider the risks, uncertainties and assumptions when evaluating forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as expressly required. by applicable securities laws.

SOURCEAurora Cannabis Inc.

Related links